Related Experiment Video
Updated: Mar 10, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Shengmai Formula suppressed over-activated Ras/MAPK pathway in C. elegans by opening mitochondrial permeability
Yan Liu1, Dejuan Zhi1, Menghui Li2
1Gansu high throughput screening and creation center for health products, School of Pharmacy, Lanzhou University, Donggang West Road No. 199, Lanzhou 730020, P.R. China.
Abstract:
Since about 30% of all human cancers contain mutationally activated Ras, down regulating the over-activation of Ras/MAPK pathway represents a viable approach for treating cancers. Over-activation of Ras/MAPK pathway is accompanied by accumulation of reactive oxygen species (ROS). One approach for developing anti-cancer drugs is to target ROS production and their accumulation. To test this idea, we have employed C. elegans of let-60 (gf) mutant, which contain over-activated let-60 (the homolog of mammalian ras) and exhibit tumor-like symptom of multivulva phenotype, to determine whether anti-oxidants can affect their tumor-like phenotype. Specifically we studied the effect of Shengmai formula (SM), a traditional Chinese medicine that has strong anti-oxidant activity, on the physiology of let-60 (gf) mutants. Unexpectedly, we found that SM treatment led to the opening of mitochondrial permeability transition pore by regulating cyclophilin D and then triggered oxidative stress and related signaling pathway activation, including p53, JNK, and p38/MAPK pathways. Finally, SM induced mitochondrial pathway of apoptosis and inhibited the tumor-like symptom of the multivulva phenotype of let-60(gf) mutants. Our results provide evidences to support that SM act as a pro-oxidant agent and could serve as a potential drug candidate for combating over-activated Ras-related cancer.
Insights
Shengmai formula (SM), a traditional Chinese medicine, unexpectedly acted as a pro-oxidant, triggering oxidative stress and apoptosis. This inhibited tumor-like growth in a Ras-related cancer model, suggesting SM as a potential anti-cancer drug.
Area of Science:
- Oncology
- Pharmacology
- Genetics
Background:
- Ras/MAPK pathway over-activation is implicated in ~30% of human cancers.
- This pathway activation is linked to increased reactive oxygen species (ROS) accumulation.
- Targeting ROS is a potential anti-cancer drug development strategy.
Purpose of the Study:
- To investigate the effect of Shengmai formula (SM), a traditional Chinese medicine with antioxidant properties, on a cancer model.
- To determine if SM can modulate the tumor-like phenotype associated with over-activated Ras/MAPK signaling.
Main Methods:
- Utilized a C. elegans let-60 (gf) mutant model exhibiting a tumor-like multivulva phenotype.
- Administered SM to assess its impact on the mutant's physiology and phenotype.
- Analyzed mitochondrial permeability transition pore opening, oxidative stress, and key signaling pathways (p53, JNK, p38/MAPK).
Main Results:
- SM treatment unexpectedly induced mitochondrial permeability transition pore opening via cyclophilin D regulation.
- This led to increased oxidative stress and activation of p53, JNK, and p38/MAPK pathways.
- SM triggered the mitochondrial apoptosis pathway and reduced the multivulva phenotype.
Conclusions:
- Shengmai formula (SM) functions as a pro-oxidant agent, not an antioxidant, in this cancer model.
- SM effectively inhibits tumor-like growth by inducing apoptosis.
- SM shows potential as a therapeutic candidate for Ras-related cancers.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
10:50Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Related Concept Videos
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene
Ras is a...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...